Key Industry Drivers Pt. 2

The video is loading
POSTED:
January 10, 2012
TAGS:
BY:
Steven H. Collis

About This Video

A CEO's Perspective

In part 2 of this candid conversation with Steve Collis, President and CEO of AmerisourceBergen, we discuss key trends in the pharmaceutical industry including:

  • Growth opportunities for the pharmaceutical industry in 2012 and beyond
  • AmerisourceBergen's progress toward becoming the industry's easiest company to work with
  • How AmerisourceBergen plans to leverage new technologies for the benefit of its customers

 

View part 1

Steven H. Collis

Steven H. Collis

Steve Collis is President and Chief Executive Officer of AmerisourceBergen Corporation. Mr. Collis previously served as President and Chief Operating Officer, responsible for all AmerisourceBergen business units including AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS), and AmerisourceBergen Packaging Group (ABPG). Previously, Mr. Collis was Executive Vice President of AmerisourceBergen and President of ABDC, the Company's largest subsidiary with revenues over $60 billion. During his tenure with the Company, Mr. Collis was the driving force behind growing and developing ABSG into the market-leader it is today, with $16 billion in annualized revenues.

Born and educated in South Africa, Mr. Collis earned a Bachelor of Commerce degree and a Bachelor of Commerce with Honors degree from the University of the Witwatersrand in Johannesburg.

Leave a Comment